Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aa48a431ce250933eb0fdd7a1caf3f30 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1611 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-204 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1688 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2003-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_409b46e81aeddcb640eca4887865a32f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_520c710af67d997aa4202ae412442a70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3d3f600d38fd037c8318fc10f8d1e2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d2e5ac4a0425007462bd5f400bfc7bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_287b4c7f395b23ae814c9f4d44ee72d2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5eaadfab4a0e5dd021c6d782dd1fb527 |
publicationDate |
2005-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-0315304-A |
titleOfInvention |
Depot formulations for controlled release |
abstract |
"FORMULATIONS WITH DEPOSIT FOR CONTROLLED RELEASE". The present invention relates to methods and compositions for systemically or locally administering a beneficial agent to an individual, and include, for example, gel depot compositions which may be injected into a desired location and which provide for the release beneficial agent over a prolonged period of time. The compositions include a biocompatible polymer; a biocompatible solvent with low water miscibility, which forms a viscous gel with the polymer and limits the uptake of water by the implant; and a beneficial agent. |
priorityDate |
2002-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |